Franklin Resources
VKTX icon

Franklin Resources’s Viking Therapeutics VKTX Stock Holding History

Franklin Resources’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$789K Sell
20,225
-30
-0.1% -$969 ﹤0.01% 2385
2026
Q1 		$659K Buy
20,255
+1,897
+10% +$61K ﹤0.01% 2361
2025
Q4 		$646K Sell
18,358
-8,776
-32% -$311K ﹤0.01% 2289
2025
Q3 		$713K Buy
27,134
+608
+2% +$18.1K ﹤0.01% 2272
2025
Q2 		$703K Sell
26,526
-159,297
-86% -$4.19M ﹤0.01% 2169
2025
Q1 		$4.49M Sell
185,823
-148,686
-44% -$4.7M ﹤0.01% 1387
2024
Q4 		$13.5M Buy
334,509
+6,385
+2% +$364K ﹤0.01% 1029
2024
Q3 		$21.6M Sell
328,124
-10,060
-3% -$590K 0.01% 870
2024
Q2 		$17.9M Sell
338,184
-2,327
-0.7% -$153K 0.01% 893
2024
Q1 		$27.9M Buy
340,511
+325,453
+2,161% +$14.5M 0.01% 760
2023
Q4 		$280K Sell
15,058
-32,680
-68% -$427K ﹤0.01% 2210
2023
Q3 		$528K Sell
47,738
-11,110
-19% -$159K ﹤0.01% 1889
2023
Q2 		$954K Buy
+58,848
New +$1.23M ﹤0.01% 1663

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources's VKTX Position: Q2 2026 in Review

Franklin Resources reduced its Viking Therapeutics (VKTX) stake by 0.15% in Q2 2026, selling an estimated $969 and leaving 20,225 shares worth $789K. The position accounts for ﹤0.01% of the portfolio, ranked #2385.

Franklin Resources first reported a position in VKTX in Q2 2023 and has held it in 13 quarters since. The position peaked at $27.9M in Q1 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Franklin Resources held 20,225 shares of Viking Therapeutics worth $789K as of Q2 2026.
  • Franklin Resources sold 30 Viking Therapeutics shares in Q2 2026, an estimated $969.
  • Viking Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2385 holding.
  • Franklin Resources first reported a position in Viking Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Franklin Resources's Viking Therapeutics position peaked at $27.9M in Q1 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.